Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Due

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
British Medical Journal|August 27, 2010
THE CONDITION OF THE MEDICAL PROFESSION IN NORWAYE Due
Ugeskrift for Laeger|May 12, 2001
[There are pediatricians outside hospitals, too]L Kirk, E Due
Journal of the European Academy of Dermatology and Venereology : JEADV|July 14, 2006
Cheilitis - the only presentation of photosensitivityE Due, H C Wulf
Ugeskrift for Laeger|June 5, 1989
[Permanent central venous catheter in pediatric oncology]P A Nielsen, H Jøhncke, E Due
The Journal of Organic Chemistry|January 27, 2010
A rapid and efficient Sonogashira protocol and improved synthesis of free fatty acid 1 (FFA1) receptor agonistsElisabeth Christiansen, Maria E Due-Hansen, Trond Ulven
Ugeskrift for Laeger|April 24, 1995
[Sex differences in health behavior and self assessed health in 11-15 years old children. A comparison between life conditions and health]L Ross-Petersen, B E Holstein, P E Due
Journal of the European Academy of Dermatology and Venereology : JEADV|March 12, 2014
Pseudoporphyria - a case reportM Gyldenløve, E Due, M F Jonkman, et al.
Organic & Biomolecular Chemistry|November 21, 2015
A protocol for amide bond formation with electron deficient amines and sterically hindered substratesMaria E Due-Hansen, Sunil K Pandey, Elisabeth Christiansen, et al.
Journal of Medicinal Chemistry|August 23, 2011
Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME propertiesElisabeth Christiansen, Christian Urban, Manuel Grundmann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 18, 2013
In vitro and mouse in vivo characterization of the potent free fatty acid 1 receptor agonist TUG-469C Urban, A Hamacher, H J Partke, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
British Medical Journal|August 27, 2010
THE CONDITION OF THE MEDICAL PROFESSION IN NORWAYE Due
Ugeskrift for Laeger|May 12, 2001
[There are pediatricians outside hospitals, too]L Kirk, E Due
Journal of the European Academy of Dermatology and Venereology : JEADV|July 14, 2006
Cheilitis - the only presentation of photosensitivityE Due, H C Wulf
Ugeskrift for Laeger|June 5, 1989
[Permanent central venous catheter in pediatric oncology]P A Nielsen, H Jøhncke, E Due
The Journal of Organic Chemistry|January 27, 2010
A rapid and efficient Sonogashira protocol and improved synthesis of free fatty acid 1 (FFA1) receptor agonistsElisabeth Christiansen, Maria E Due-Hansen, Trond Ulven
Ugeskrift for Laeger|April 24, 1995
[Sex differences in health behavior and self assessed health in 11-15 years old children. A comparison between life conditions and health]L Ross-Petersen, B E Holstein, P E Due
Journal of the European Academy of Dermatology and Venereology : JEADV|March 12, 2014
Pseudoporphyria - a case reportM Gyldenløve, E Due, M F Jonkman, et al.
Organic & Biomolecular Chemistry|November 21, 2015
A protocol for amide bond formation with electron deficient amines and sterically hindered substratesMaria E Due-Hansen, Sunil K Pandey, Elisabeth Christiansen, et al.
Journal of Medicinal Chemistry|August 23, 2011
Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME propertiesElisabeth Christiansen, Christian Urban, Manuel Grundmann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 18, 2013
In vitro and mouse in vivo characterization of the potent free fatty acid 1 receptor agonist TUG-469C Urban, A Hamacher, H J Partke, et al.
Pageof 2